Subjective memory complaints in preclinical autosomal dominant Alzheimer disease

Conclusions: Cognitively unimpaired PSEN-1 carriers have elevated SMC. Self-reported SMC may be a relatively early indicator of preclinical AD, while partner- reported SMC increases later in preclinical AD, closer to clinical onset.

http://www.neurology.org/cgi/content/short/89/14/1464?rss=1

Source: Neurology - October 2, 2017 Category: Neurology Authors: Norton, D. J., Amariglio, R., Protas, H., Chen, K., Aguirre-Acevedo, D. C., Pulsifer, B., Castrillon, G., Tirado, V., Munoz, C., Tariot, P., Langbaum, J. B., Reiman, E. M., Lopera, F., Sperling, R. A., Quiroz, Y. T. Tags: Alzheimer's disease, Cognitive aging, Assessment of cognitive disorders/dementia ARTICLE Source Type: research